MXPA05010254A - Composicion farmaceutica que contiene complejo de platino como sustancia activa y metodo de fabricacion de la misma. - Google Patents
Composicion farmaceutica que contiene complejo de platino como sustancia activa y metodo de fabricacion de la misma.Info
- Publication number
- MXPA05010254A MXPA05010254A MXPA05010254A MXPA05010254A MXPA05010254A MX PA05010254 A MXPA05010254 A MX PA05010254A MX PA05010254 A MXPA05010254 A MX PA05010254A MX PA05010254 A MXPA05010254 A MX PA05010254A MX PA05010254 A MXPA05010254 A MX PA05010254A
- Authority
- MX
- Mexico
- Prior art keywords
- active substance
- pharmaceutical composition
- platinum complex
- manufacturing
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invencion se refiere a una composicion farmaceutica que contiene el complejo de platino de la formula (I) como una sustancia activa en la cual, A, A??, B, B??, X y X?? tienen significados especificos, en una mezcla con por lo menos un excipiente farmaceuticamente aceptable, caracterizado porque esta se forma a partir de un granulado con particulas con tamano mas pequeno de 0.5 mm que se preparan mediante granulacion en humedo de una mezcla de complejo de platino de platino tetravalente de la formula (I) humectado con agua, por lo menos un sacarido neutro y por lo menos un polisacarido original y/o modificado, estando contenida opcionalmente en una capsula o en una bolsa o se compacta opcionalmente en forma de una tableta, mientras que la superficie del granulado, la capsula o la tableta este recubierto opcionalmente con una capa de por lo menos una sustancia farmaceuticamente aceptable que permita la disolucion entero-solvente de la sustancia activa unicamente, en intestinos y/o por lo menos una sustancia farmaceuticamente aceptable que permite la liberacion controlada de la sustancia activa. La invencion se refiere tambien a un metodo para fabricar dicha composicion farmaceutica.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ2003915A CZ296045B6 (cs) | 2003-03-31 | 2003-03-31 | Farmaceutická kompozice obsahující jako účinnou látku komplex čtyřmocné platiny a způsob její výroby |
CZ2004235A CZ2004235A3 (cs) | 2004-02-12 | 2004-02-12 | Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice |
PCT/CZ2004/000017 WO2004087126A1 (en) | 2003-03-31 | 2004-03-30 | Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05010254A true MXPA05010254A (es) | 2006-02-22 |
Family
ID=33132424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05010254A MXPA05010254A (es) | 2003-03-31 | 2004-03-30 | Composicion farmaceutica que contiene complejo de platino como sustancia activa y metodo de fabricacion de la misma. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20060063832A1 (es) |
EP (1) | EP1608358A1 (es) |
JP (1) | JP2006521300A (es) |
BR (1) | BRPI0408805A (es) |
CA (1) | CA2517120C (es) |
HR (1) | HRP20050902A2 (es) |
MX (1) | MXPA05010254A (es) |
NO (1) | NO20054897L (es) |
RS (1) | RS20050714A (es) |
RU (1) | RU2343913C2 (es) |
UA (1) | UA80872C2 (es) |
WO (1) | WO2004087126A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002060446A1 (en) | 2001-01-29 | 2002-08-08 | Shionogi & Co., Ltd. | Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
CZ2004235A3 (cs) * | 2004-02-12 | 2005-08-17 | Pliva-Lachema A. S. | Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice |
CZ296459B6 (cs) * | 2004-09-14 | 2006-03-15 | Pliva-Lachema A. S. | Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
NZ591443A (en) * | 2005-09-22 | 2013-04-26 | Intermune Inc | Granule formation of pirfenidone and pharmaceutically acceptable excipients |
CZ300590B6 (cs) * | 2006-06-20 | 2009-06-24 | Pliva - Lachema A. S. | Farmaceutická kompozice pro injekcní podání |
MY151207A (en) * | 2007-12-27 | 2014-04-30 | Taiho Pharmaceutical Co Ltd | Oral particulate antitumor preparation |
CN105295058B (zh) * | 2009-02-04 | 2018-09-21 | 布里格姆及妇女医院股份有限公司 | 纳米级铂化合物及其使用方法 |
CA3004630A1 (en) | 2015-12-09 | 2017-06-15 | Medizinische Universitat Wien | Monomaleimide-functionalized platinum compounds for cancer therapy |
CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4302446A (en) * | 1979-10-02 | 1981-11-24 | Bristol-Myers Company | Pharmaceutical compositions |
JPS5970614A (ja) * | 1982-10-14 | 1984-04-21 | Asahi Chem Ind Co Ltd | 微量主薬系湿式固形製剤方法 |
US5240954A (en) * | 1985-06-25 | 1993-08-31 | Glaxo Group Limited | Medicaments |
US5256653A (en) * | 1987-02-19 | 1993-10-26 | Henkel Kommanditgesellschaft Auf Aktien | Pharmaceutical preparations containing platinum complexes/phosphonic acid liquid and processes for their use |
FI905018A0 (fi) * | 1989-10-17 | 1990-10-12 | Bristol Myers Squibb Co | I vatten och loesningsmedel loesliga axiala hydroxi-och mono- och dikarboxylsyraderivat med stor tumoeraktivitet. |
IT1241417B (it) * | 1990-03-06 | 1994-01-14 | Vectorpharma Int | Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione |
IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
FR2729857B1 (fr) * | 1995-01-27 | 1997-04-04 | Rhone Poulenc Chimie | Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire |
JPH10265380A (ja) * | 1997-03-17 | 1998-10-06 | Bristol Myers Squibb Co | 抗ガン剤 |
CZ288912B6 (cs) * | 1998-05-27 | 2001-09-12 | Lachema, A. S. | Komplex platiny v oxidačním čísle IV, způsob přípravy tohoto komplexu, tento komplex jako léčivo a farmaceutická kompozice tento komplex obsahující |
KR100317473B1 (ko) * | 1999-05-11 | 2001-12-22 | 이계호 | 신규의 백금(iv)착제 및 그 제조방법 |
JP2001347153A (ja) * | 2000-06-12 | 2001-12-18 | Asahi Kasei Corp | 錠剤の製造方法 |
-
2004
- 2004-03-30 RS YUP-2005/0714A patent/RS20050714A/sr unknown
- 2004-03-30 JP JP2006504221A patent/JP2006521300A/ja active Pending
- 2004-03-30 UA UAA200510188A patent/UA80872C2/uk unknown
- 2004-03-30 BR BRPI0408805-0A patent/BRPI0408805A/pt not_active IP Right Cessation
- 2004-03-30 MX MXPA05010254A patent/MXPA05010254A/es unknown
- 2004-03-30 EP EP04724245A patent/EP1608358A1/en not_active Withdrawn
- 2004-03-30 CA CA2517120A patent/CA2517120C/en not_active Expired - Fee Related
- 2004-03-30 US US10/549,296 patent/US20060063832A1/en not_active Abandoned
- 2004-03-30 RU RU2005133428/15A patent/RU2343913C2/ru not_active IP Right Cessation
- 2004-03-30 WO PCT/CZ2004/000017 patent/WO2004087126A1/en active Application Filing
-
2005
- 2005-10-17 HR HR20050902A patent/HRP20050902A2/hr not_active Application Discontinuation
- 2005-10-24 NO NO20054897A patent/NO20054897L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2517120A1 (en) | 2004-10-14 |
NO20054897L (no) | 2005-10-24 |
RU2005133428A (ru) | 2006-05-10 |
JP2006521300A (ja) | 2006-09-21 |
UA80872C2 (uk) | 2007-11-12 |
WO2004087126A1 (en) | 2004-10-14 |
RU2343913C2 (ru) | 2009-01-20 |
US20060063832A1 (en) | 2006-03-23 |
HRP20050902A2 (en) | 2005-12-31 |
EP1608358A1 (en) | 2005-12-28 |
AU2004226898A1 (en) | 2004-10-14 |
CA2517120C (en) | 2012-09-18 |
RS20050714A (sr) | 2008-04-04 |
BRPI0408805A (pt) | 2006-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sharma et al. | Low density multiparticulate system for pulsatile release of meloxicam | |
JP5154924B2 (ja) | ジェランガムを含む膨張可能な投与形態 | |
RS20070511A (en) | Modified release pharmaceutical compositions and processes thereof | |
NZ710384A (en) | A novel formulation of indomethacin | |
ES2543427T3 (es) | Forma farmacéutica oral de deferasirox | |
IL180943A0 (en) | Multiparticle pharmaceutical dosage form for a low-soluble active substances and method for producing said pharmaceutical dosage form | |
CN103313698A (zh) | 多颗粒胃滞留剂型的制备方法 | |
NO20054897L (no) | Farmasoytisk preparat inneholdende platinakompleks som aktiv substans og fremgangsmate for fremstilling derav | |
MX2008001645A (es) | Composiciones de fexofendina en suspension farmaceutica oral. | |
Kuno et al. | Effect of preparation method on properties of orally disintegrating tablets made by phase transition | |
WO2006041843A3 (en) | Pharmaceutical dosage form comprising meloxicam | |
TW201206453A (en) | New use of diatomaceous earth in the pharmaceutical industry | |
DE69904954D1 (de) | Verfahren zur herstellung neuer fenofibrathaltiger arzneiformulierungen, dadurch hergestellte arzneiformulierungen und ihre verwendung | |
DE60212464D1 (de) | Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit | |
BR9909637A (pt) | Processo para a produção de um tablete de uma composição particulada compactada, tablete de composição particulada compactada, e, usos de cristais ou acetato de sódio hidratado ou anidro, acetato de potássio ou misturas dos mesmos e de cristais ou triidrato de acetato de sódio hidratado ou anidro, acetato de potássio ou mistura dos mesmos | |
JP5721093B2 (ja) | 崩壊錠 | |
JP2006282551A (ja) | 口腔内崩壊錠およびその製造方法 | |
MX2009004124A (es) | Nanoparticulas micelares de sustancias quimicas. | |
CN1364464A (zh) | 盐酸氨基葡萄糖药物组合物 | |
WO2008084676A1 (ja) | 多孔性乾燥マトリックスの医薬組成物 | |
WO2007128350A1 (en) | Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions | |
WO2004078108A3 (fr) | Comprime de fenofibrate et procede de fabrication | |
WO2004026261A3 (en) | Composition containing ribavirin and use thereof | |
JP2004075594A (ja) | 経口用ウコン類組成物 | |
CA2532714A1 (en) | Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide |